Whole brain radiotherapy with hippocampal sparing using Varian HyperArc.

Autor:	Sprowls CJ; Department of Radiation Oncology, Orlando Health Cancer Institute, Orlando, FL, USA. Electronic address: Cameron.Sprowls@orlandohealth.com., Shah AP; Department of Radiation Oncology, Orlando Health Cancer Institute, Orlando, FL, USA., Kelly P; Department of Radiation Oncology, Orlando Health Cancer Institute, Orlando, FL, USA., Burch DR; Department of Radiation Oncology, Orlando Health Cancer Institute, Orlando, FL, USA., Mathews RS; Department of Radiation Oncology, Orlando Health Cancer Institute, Orlando, FL, USA., Swanick CW; Department of Radiation Oncology, Orlando Health Cancer Institute, Orlando, FL, USA., Meeks SL; Department of Radiation Oncology, Orlando Health Cancer Institute, Orlando, FL, USA.
Jazyk:	angličtina
Zdroj:	Medical dosimetry : official journal of the American Association of Medical Dosimetrists [Med Dosim] 2021 Autumn; Vol. 46 (3), pp. 264-268. Date of Electronic Publication: 2021 Mar 24.
DOI:	10.1016/j.meddos.2021.02.007
Abstrakt:	The purpose of this work was to evaluate using Varian HyperArc as a planning and treatment solution for whole brain radiotherapy (WBRT) with hippocampal sparing following Radiation Therapy Oncology Group (RTOG) 0933 dosimetric criteria. Ten patients previously treated for intracranial lesions were retrospectively planned for WBRT with hippocampal sparing using HyperArc and a 2-arc coplanar VMAT technique. The whole brain and hippocampus were delineated on fused MRI and CT datasets. The planning target volume (PTV), defined as the whole brain excluding the hippocampal avoidance region, was prescribed 30 Gy in 10 fractions. Plans were evaluated using dosimetric parameters which included the volume of 105% of the prescription dose (V105%) and the maximum dose to the PTV, and the minimum dose to the hippocampus. The planning time, delivery time, and delivery quality assurance (QA) results were also evaluated. Statistical significance was performed between the HyperArc and coplanar VMAT metrics using the Wilcoxon signed-rank test with a significance level of 0.05. All plans met RTOG 0933 dosimetric criteria. HyperArc plans demonstrated significant improvements in PTV dosimetric quality which included a reduced V105% of 6 ± 7% and decreased maximum dose of 1.3 ± 0.3 Gy, compared to coplanar VMAT. Significant OAR sparing was also found for HyperArc plans that included a decreased minimum dose to the hippocampus of 0.3 ± 0.3 Gy. Coplanar VMAT plans resulted in significantly shorter planning and delivery times, compared to HyperArc, by 2.4 minutes and 1.5 minutes, respectively. No significant difference was found between the delivery QA results. This study demonstrated using Varian HyperArc as a planning and treatment solution for WBRT with hippocampal sparing following RTOG 0933 dosimetric criteria. The primary advantages of WBRT with hippocampal sparing using HyperArc, compared to coplanar VMAT, are the gains in OAR sparing and reduced high dose volumes to the PTV. (Copyright © 2021 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu